Clin2
NCT06069063Possibly a fitNot yet recruiting

Zafirlukast for preventing cat allergy symptoms

Allergy to Cats

Part of Immune system & allergy clinical trials.

This study tests a medication called zafirlukast to see if it can prevent allergic reactions to cat dander. It might help reduce symptoms like sneezing, itching, and stuffiness when you're around cats.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 2
Enrollment
12 people
Ages
18 years to 65 years
Study type
Interventional

Who can take part

  • You must be 18 to 65 years old and not smoke.
  • You need to have hay fever symptoms triggered by cat dander.
  • Your blood pressure and heart rate at rest must be within normal limits (blood pressure below 140/90, heart rate below 100).
  • You must not be taking daily preventive asthma medication; only occasional use for mild symptoms is allowed.
  • You cannot have a cat at home or work with cats.
  • If you are a woman of childbearing age, you must have a negative pregnancy test, not be nursing, and use reliable birth control.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT00595491Recruiting· Phase 1
Study immune targets in cat and dust-mite allergic airway inflammation

This Phase 1 study looks at how the immune system drives allergic airway inflammation in people with allergic asthma, and compares them with allergic non-asthma and non-allergic healthy volunteers. The goal is to identify immune “signals” and cell “receptors” involved, which may guide better future treatments.

Boston, Massachusetts
NCT06960382Recruiting· Phase 1/Phase 2
Cat allergy immunotherapy with lymph node injections

This trial tests a new way to treat cat allergies by giving tiny injections directly into a lymph node (a part of your immune system), instead of under the skin. It aims to see if this method is safe and can reduce cat allergy symptoms, even in people with asthma.

Zurich
NCT07114133Enrolling by invitation
Environmental probiotics for cat hair allergies

This study tests whether a special probiotic spray, used in your home, can reduce allergy symptoms in people who are allergic to cats. If you have cat allergies with nasal symptoms and live in a stable home, you may be able to join.

Hangzhou, Zhejiang
NCT07675811Recruiting· Phase 3
Study of a new treatment for cat allergy related eye symptoms

This trial tests an injectable treatment that may help manage eye allergy symptoms caused by cat allergies. It aims to see if the treatment is safe and effective for adults and children, and includes a controlled cat exposure challenge.

Andover, Massachusetts
NCT07447869Recruiting· Early Phase 1
Lymph Node Exam in Cat Allergy Treatment Study

This study looks at lymph nodes in the neck to understand how the body responds to cat allergy treatments. It may help researchers improve allergy shots or other therapies for people with cat allergies.

Boston, Massachusetts
NCT05331170Recruiting· Phase 2
Re-training the nose to change how allergies behave

This Phase 2 study tests a “viral” treatment meant to reprogram the lining of your nose to reduce allergy-like immune responses. It is testing whether this approach is safe and can help people with cat allergy (with or without asthma) or compare against healthy people.

Galveston, Texas

Hear when a new Allergy to Cats trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.